FTC sues major pharmacy gain supervisors about insulin selling prices The agency brought motion against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-conserving insulin medicines. Pay attention to the post ten min This audio is car-generated. Make sure https://martinjeaxt.daneblogger.com/30035375/everything-about-healthcare-news